Finding cancers missed during the pandemic
As many of you know, the COVID-19 pandemic has delayed [...]
Delayed nephrectomy after immunotherapy for metastatic kidney cancer
Neoadjuvant therapy is the treatment given as a first step [...]
Does the time to start first-line treatment influence survival of patients with low risk kidney cancer?
Many patients with low-risk or favourable-risk kidney cancer may have [...]
55,000 cancer patients miss treatment target over 6 years
Cancer Research UK has reported that over the past 6 [...]
Effect of treatment delay on outcomes in metastatic kidney cancer
A recent study published in Science Direct followed patients with [...]
